Clinical Outcome of Everolimus Treatment of Advanced Neuroendocrine Neoplasms: “Real-life” Data from the German NET-Register Abstract #1200

Introduction: Everolimus (EVE) has importantly impacted the treatment (Tx) of mostly pancreatic NEN.
Aim(s): This study analyzed recent results of routine EVE-Tx from 5 centres of the German NET-Register.
Materials and methods: Multicentric, retrospective analysis of pts. with histologically proven NEN progressive prior to Tx initiation with EVE (initial diagnosis 1988-2013); statistical analysis used SPSS 19.0.
Conference: 12th Annual ENETS Conference 2015 (2015)
Category: Medical treatment - Targeted therapies
Presenting Author: Sebastian Maasberg
Keywords: everolimus, outcome

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result